EPH3 Comparing Cardiac Safety Profile of Metformin and Sulfonylureas in Colorectal Cancer (CRC) Patients with Type 2 Diabetes Mellitus (T2DM): Surveillance, Epidemiology and End Results (SEER) Medicare Analysis
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.886
https://www.valueinhealthjournal.com/article/S1098-3015(23)00986-5/fulltext
Title :
EPH3 Comparing Cardiac Safety Profile of Metformin and Sulfonylureas in Colorectal Cancer (CRC) Patients with Type 2 Diabetes Mellitus (T2DM): Surveillance, Epidemiology and End Results (SEER) Medicare Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00986-5&doi=10.1016/j.jval.2023.03.886
First page :
Section Title :
Open access? :
No
Section Order :
10343